首页|University of Verona Reports Findings in Disease Progression (Tumor upgrading am ong very favorable intermediate-risk prostate cancer patients treated with robot -assisted radical prostatectomy: how can it impact the clinical course?)
University of Verona Reports Findings in Disease Progression (Tumor upgrading am ong very favorable intermediate-risk prostate cancer patients treated with robot -assisted radical prostatectomy: how can it impact the clinical course?)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Disease Attributes - D isease Progression is the subject of a report.According to news reporting from Verona, Italy, by NewsRx journalists, research stated, “We sought toinvestigate predictors of unfavorable tumor upgrading in very favorable intermediate-risk ( IR) prostatecancer (PCa) patients treated with robot-assisted radical prostatec tomy, in addition to evaluate how itmay affect the risk of disease progression. A very favorable subset of IR PCa patients presenting withprostate-specific an tigen (PSA) <10 ng/mL, percentage of biopsy positive cores (BPC) <50%, and eitherInternational Society of Urological Pathology (ISUP) grade group 1 and clinical stage T2b or ISUP gra degroup 2 and clinical stage T1c-2b was identified.”
VeronaItalyEuropeCancerDisease A ttributesDisease ProgressionEmerging TechnologiesHealth and MedicineMach ine LearningOncologyPathologyProstate CancerProstatectomyProstatic Neo plasmsRisk and PreventionRobotRoboticsSurger
NETL
NSTL
